Cadre (CDRE) Competitors $32.22 +0.31 (+0.97%) As of 07/3/2025 03:42 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CDRE vs. IRTC, NARI, TMDX, BLCO, SLNO, INSP, NVST, PRCT, LIVN, and WRBYShould you be buying Cadre stock or one of its competitors? The main competitors of Cadre include iRhythm Technologies (IRTC), Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. Cadre vs. Its Competitors iRhythm Technologies Inari Medical TransMedics Group Bausch + Lomb Soleno Therapeutics Inspire Medical Systems Envista PROCEPT BioRobotics LivaNova Warby Parker Cadre (NYSE:CDRE) and iRhythm Technologies (NASDAQ:IRTC) are both medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, valuation, dividends and risk. Which has more volatility & risk, CDRE or IRTC? Cadre has a beta of 1.31, suggesting that its share price is 31% more volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.41, suggesting that its share price is 41% more volatile than the S&P 500. Is CDRE or IRTC more profitable? Cadre has a net margin of 6.87% compared to iRhythm Technologies' net margin of -15.90%. Cadre's return on equity of 12.52% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Cadre6.87% 12.52% 6.04% iRhythm Technologies -15.90%-101.04%-9.55% Does the media favor CDRE or IRTC? In the previous week, iRhythm Technologies had 2 more articles in the media than Cadre. MarketBeat recorded 7 mentions for iRhythm Technologies and 5 mentions for Cadre. iRhythm Technologies' average media sentiment score of 0.64 beat Cadre's score of 0.34 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cadre 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral iRhythm Technologies 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend CDRE or IRTC? Cadre currently has a consensus price target of $37.50, indicating a potential upside of 16.39%. iRhythm Technologies has a consensus price target of $138.60, indicating a potential downside of 2.64%. Given Cadre's higher possible upside, equities analysts clearly believe Cadre is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cadre 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50iRhythm Technologies 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90 Do insiders and institutionals believe in CDRE or IRTC? 44.0% of Cadre shares are owned by institutional investors. 37.0% of Cadre shares are owned by insiders. Comparatively, 1.1% of iRhythm Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has higher earnings and valuation, CDRE or IRTC? Cadre has higher earnings, but lower revenue than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCadre$567.56M2.31$36.13M$0.9533.92iRhythm Technologies$591.84M7.68-$113.29M-$3.14-45.34 SummaryCadre beats iRhythm Technologies on 9 of the 16 factors compared between the two stocks. Get Cadre News Delivered to You Automatically Sign up to receive the latest news and ratings for CDRE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDRE vs. The Competition Export to ExcelMetricCadrePROTECTION IndustryIndustrials SectorNYSE ExchangeMarket Cap$1.31B$2.03B$7.52B$20.72BDividend Yield1.18%1.86%4.53%3.71%P/E Ratio33.9239.8424.9628.09Price / Sales2.314.78118.7538.30Price / Cash22.7561.3727.4522.53Price / Book4.209.614.364.58Net Income$36.13M$110.42M$791.63M$986.06M7 Day Performance0.57%6.25%2.18%2.79%1 Month Performance-5.19%9.48%5.71%5.46%1 Year Performance-6.99%186.55%31.83%15.06% Cadre Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDRECadre3.6847 of 5 stars$32.22+1.0%$37.50+16.4%-5.3%$1.31B$567.56M33.922,284IRTCiRhythm Technologies1.0805 of 5 stars$153.96-0.5%$138.60-10.0%+47.1%$4.94B$591.84M-49.032,000Insider TradeNARIInari MedicalN/A$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800TMDXTransMedics Group1.6322 of 5 stars$134.01+1.9%$127.33-5.0%-13.9%$4.45B$441.54M98.54210Positive NewsBLCOBausch + Lomb3.3939 of 5 stars$13.03+5.1%$15.54+19.3%-5.7%$4.39B$4.79B-12.6513,500High Trading VolumeSLNOSoleno Therapeutics4.3833 of 5 stars$83.78+0.6%$107.10+27.8%+106.1%$4.20BN/A-18.1330Insider TradeINSPInspire Medical Systems4.8525 of 5 stars$129.28-2.4%$211.91+63.9%-4.1%$3.91B$802.80M59.581,246Positive NewsNVSTEnvista3.758 of 5 stars$19.58-0.5%$20.23+3.3%+25.2%$3.33B$2.51B-3.0012,300News CoveragePRCTPROCEPT BioRobotics2.4464 of 5 stars$57.60+1.2%$90.00+56.3%-7.3%$3.15B$224.50M-33.88430LIVNLivaNova3.2467 of 5 stars$45.02-1.6%$59.29+31.7%-12.6%$2.49B$1.25B-11.012,900News CoveragePositive NewsWRBYWarby Parker2.2278 of 5 stars$21.94+0.2%$22.88+4.3%+37.1%$2.29B$771.32M-182.833,780Positive News Related Companies and Tools Related Companies IRTC Alternatives NARI Alternatives TMDX Alternatives BLCO Alternatives SLNO Alternatives INSP Alternatives NVST Alternatives PRCT Alternatives LIVN Alternatives WRBY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CDRE) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadre Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadre With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDRE Stock Alerts